Best Grants for Cancer Nonprofits in Montana

Siemens Healthineers supports charitable donations that align with its focus areas, including diagnostic imaging and oncology. They prioritize well-rated organizations that allocate a significant portion of donations to clinical efforts rather than administrative costs. Events must ensure at least 65% of funds go to the intended cause. Local chapters of national nonprofits should coordinate with their national teams for requests, as Siemens typically does not entertain separate local requests.

The RFA: Biology to Prevention Award (CRUK) aims to foster innovative translational research that enhances understanding of cancer biology, ultimately leading to effective prevention strategies. Joint applications from UK and US research teams are encouraged, with a focus on equal partnerships and complementary expertise. The funding provides up to £600,000 for UK costs and up to $946,000 for US costs, supporting projects of 1 to 5 years duration that address critical research questions in cancer prevention.

The Anna Fuller Fund Grant provides year-round support for organizations dedicated to alleviating suffering caused by cancer. Established in memory of Egbert C. Fuller’s wife, the fund prioritizes applications that focus on cancer research and education initiatives. Eligible applicants must be 501(c)(3) organizations or equivalent charities outside the U.S. Grant funds cannot be used for direct treatment, ensuring that resources are allocated to research and public education.

The James Paul Sutton Medical Research Fund Grant supports non-profit organizations engaged in cancer and medical research, established through a trust by the Sutton family. Eligible organizations must be 501(c)(3) exempt. Preference is given to cancer research initiatives, while grants are not available for individuals, political groups, or for-profit entities. This fund aims to sustain medical research efforts for the long term, continuing the legacy of the Sutton family.

The National Cancer Institute (NCI) plans to issue a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12). This program aims to enhance training for clinician-scientists in cancer research, fostering their career development and collaboration with basic research scientists. It mandates diverse oncology specialties in faculty, individualized career development plans, and mentorship, supporting Scholars for up to three years to promote their research initiatives in clinical trials.

The Simeon J. Fortin Charitable Foundation, founded in 1986, champions cancer research initiatives aimed at finding a cure. It supports relevant projects and fellowships within medical and research institutions, ensuring a significant impact on health-related research. The grant review process is conducted by The Medical Foundation, in coordination with the King Trust Postdoctoral Fellowships, enhancing collaboration and funding opportunities for innovative research in oncology.

The AGD Foundation Grant Program supports nonprofit organizations in the U.S. and Canada that provide free oral cancer screenings and education, particularly for underserved communities. Established in 1972, the AGD Foundation aims to enhance public oral health and raise awareness about oral/oropharyngeal cancer. By promoting early detection and education, the foundation seeks to improve survival rates and empower communities. Eligible applicants must be 501(c)(3) organizations demonstrating a commitment to community health.

The EMF SAMFund Financial Assistance Grants support young adult cancer survivors facing financial hardships due to their diagnosis. With 80,000 young adults diagnosed with cancer each year in the U.S., these grants provide critical assistance for essential living expenses like rent, car payments, and education. By prioritizing applicants who demonstrate financial need and articulate how the grant will aid their recovery, the program aims to alleviate financial toxicity and empower survivors to move forward with their lives.

The EMF Family Building Grants, offered by the Expect Miracles Foundation, support young adult cancer survivors in their fertility treatment and family-building efforts. These grants are designed for applicants with a clear family-building plan and financial strategy, helping bridge the gap in costs associated with fertility preservation, assisted reproductive technologies, and related services. By prioritizing those actively engaged in their journey, the foundation aims to empower survivors to pursue their dreams of family.

Individuals being treated for Waldenstrom macroglobulinemia in Montana can apply for Healthwell Foundation’s patient assistance grants; awards Up to US $8,000 for prescription drug copays and Medicare Part B premiums. Eligible applicants must be underinsured, receiving treatment in the U.S., have insurance covering their medications, and meet income guidelines up to 500% of the Federal Poverty Level.

Cancer researchers at U.S. academic institutions or eligible nonprofits, including those in Montana, can apply for American Cancer Society and Fanconi Cancer Foundation support for high-risk, high-reward translational projects on Fanconi anemia–related cancers. Grants provide more than US $135,000 to advance detection, prevention, or treatment strategies tailored to individuals with FA.

Individuals in the U.S. being treated for mantle cell lymphoma who are underinsured can receive up to US $8,500 to help cover prescription drug copays and Medicare Part B premiums. Grants from Healthwell Foundation help patients, including those in Montana, reduce out-of-pocket costs for covered lymphoma treatments when income and insurance criteria are met.

Underinsured U.S. patients being treated for chronic lymphocytic leukemia can receive up to US $8,000 to cover prescription drug copays and Medicare Part B insurance premiums. With a mission to reduce financial barriers to care, Healthwell Foundation provides this support, which may benefit Montana cancer patients meeting its medical, insurance, and income guidelines.

Individuals in Montana receiving treatment in the U.S. for cancer-related behavioral health conditions can get up to US $2,000 to offset prescription drug copays, counseling, psychotherapy, and related transportation costs. The Healthwell Foundation bases eligibility on diagnosis, insurance coverage, and income, helping underinsured cancer patients access needed behavioral health care.

Underinsured patients being treated for amyloidosis in Montana and across the U.S. can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums. The HealthWell Foundation supports individuals whose insurance covers part of their medication costs and whose household income falls within its federal poverty level guidelines.

Elderly professional blues musicians in Montana facing medical or basic living emergencies can receive assistance for healthcare, transportation, utilities, or burial costs. Pinetop Perkins Foundation provides this support nationwide, and Montana cancer-focused nonprofits may connect qualifying artists in crisis with this $500 Pinetop Assistance League (PAL) grant.

Cancer research organizations and healthcare institutions in Montana can apply for up to US $13,000,000 to conduct patient-centered comparative clinical effectiveness research across the cancer care continuum. With a mission to improve healthcare decisions, Patient-Centered Outcomes Research Institute supports researcher–community partnerships that address screening barriers, treatment delivery, and survivorship needs for U.S. patients and caregivers.

Montana cancer and health research organizations conducting retrospective observational comparative effectiveness studies can access funding through the Patient-Centered Outcomes Research Institute. Projects must use existing data sources and address at least one approved topic, such as cancer, pain, substance use, maternal morbidity and mortality, intellectual and developmental disabilities, sensory health, metabolic and endocrine health, mental and behavioral health, or rare diseases, with awards up to US $2,000,000.

Cancer research institutions and translational research centers in Montana and other U.S. jurisdictions can seek funding to develop organ-specific or biologically related cancer SPORE programs. National Institutes of Health P50 center grants support state-of-the-art translational projects aimed at improving prevention, early detection, diagnosis, and treatment of human cancers, including cross-cutting themes like pediatric cancers or epigenetics.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support, including certifications and conferences. The Heart of Illinois Community Foundation scholarship may benefit Montana cancer nonprofits whose staff or beneficiaries have ties to these Illinois regions.

Full-time radiation oncology faculty clinicians conducting cancer research in Montana can seek career development support through the ASTRO-ACS Clinician Scientist Development Grant, receiving US $135,000 annually for 3–5 years. Focused on cancer/oncology, this program from the American Society for Radiation Oncology and the American Cancer Society helps clinicians become independent clinician scientists.

Practicing radiation oncologists conducting cancer research in the U.S., including Montana, can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years. This American Society for Radiation Oncology partnership supports clinician-scientists studying questions across the cancer care continuum.

Montana cancer and healthcare organizations, including hospitals, medical schools, patient advocacy groups, and eligible 501(c)(3) nonprofits, can access funding through Incyte for programs focused on healthcare information and patient care. Support may cover cancer and other disease-related education, nursing, and professional training that improve the lives of patients and caregivers.

Cancer-focused medical schools, hospitals, patient advocacy groups, and other eligible nonprofits in Montana can seek funding for healthcare information initiatives, education, and patient support. Focused on improving the lives of patients with cancer and other diseases, Incyte invites healthcare-related charitable contribution, sponsorship, and membership requests that align with its compliance and regulatory guidelines.

The 2026 Radiation Oncology Institute- Innovation Awards aim to advance cancer treatment by integrating radiation therapy with immunotherapy. Researchers are invited to submit proposals that explore optimal combinations of these modalities to enhance patient outcomes. Funding of up to $100,000 over two years will support projects focused on identifying effective treatment strategies, understanding mechanisms of synergy, and improving access to care. This initiative represents a significant opportunity for innovative research in oncology.

The CDC's initiative focuses on developing clinical decision support (CDS) tools for cancer screening and management, specifically for cervical, breast, and colorectal cancers. The project aims to enhance guideline-concordant screening and improve management processes through rigorous implementation and evaluation within large health systems. By integrating these tools into electronic health records, the initiative seeks to support clinicians in making evidence-based decisions at the point of care, ultimately improving patient outcomes in cancer care.

The Health Promotion and Disease Prevention Research Centers are offering supplemental funding for Special Interest Projects (SIPs) aimed at enhancing public health practices. These projects will focus on innovative health promotion and disease prevention strategies to mitigate leading health risks in the U.S. The initiative supports ten specific SIPs, including studies on cancer care, alcohol use reduction, and emergency preparedness, thereby fostering research that translates into real-world health improvements.